ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

Physician Clinical Investigator Awards

April 15, 1983

Caryn Lerman Recruited By Univ. Of Pennsylvania.

September 28, 2001

In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review

November 3, 1978

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

January 30, 2009

Henles to Get Bristol-Myers $25,000 Award

March 23, 1979